Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-20 | Russell H. Ellison, M.D. has been a director since January 2020 and the Company’s CEO and President since April 2020. ... Dr. Ellison serves as the Company’s President and CEO, as well as a Class III Director. ... Directors who are employed by the Company do not receive separate compensation for their service as a director. |
| 2021-04-30 | Russell H. Ellison, M.D. has been a director since January 2020 and the Company’s Chief Executive Officer and President since April 2020. ... Dr. Ellison has held leadership positions in both emerging biotechnology and large pharmaceutical companies for more than four decades, and has extensive knowledge of the renal and anemia space. |
| 2022-04-08 | Russell H. Ellison, M.D. 74 President and Chief Executive Officer, Director. Dr. Ellison is the Company’s CEO and President. |
Data sourced from SEC filings. Last updated: 2026-03-05